Publications by authors named "Ryotaro Nakamura"

100Publications

Feasibility of geriatric assessment before transplant conditioning regimen in older HCT recipients.

Bone Marrow Transplant 2020 Sep 29. Epub 2020 Sep 29.

Department of Population Sciences, Beckman Research Institute at City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-020-01064-1DOI Listing
September 2020

Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host-disease-associated autoimmunity.

J Clin Invest 2020 Sep 15. Epub 2020 Sep 15.

Diabetes and Metabolism Research Institute, Beckman Research Institute of City of Hope, Duarte, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI135468DOI Listing
September 2020

Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.

Biol Blood Marrow Transplant 2020 Aug 29. Epub 2020 Aug 29.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope Medical Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.08.027DOI Listing
August 2020

Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant.

Transfusion 2020 Aug 3. Epub 2020 Aug 3.

Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15961DOI Listing
August 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.

Blood Adv 2020 Jul;4(13):3180-3190

Center for International Blood and Marrow Transplant Research, Department of Medicine, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019001266DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362362PMC
July 2020

Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.

Am J Hematol 2020 Jul 6. Epub 2020 Jul 6.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Gehr Family Center for Leukemia Research, Duarte, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25929DOI Listing
July 2020

Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2020 Aug 19;26(8):1425-1432. Epub 2020 May 19.

Department of Hematology and HCT, City of Hope, Duarte, California; Department of Computational Quantitative Medicine/BRI, City of Hope, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.04.015DOI Listing
August 2020

Decision Analysis of Transplantation for Patients with Myelodysplasia: "Who Should We Transplant Today?"

Curr Hematol Malig Rep 2020 Aug;15(4):305-315

Department of Hematology & Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA, 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-020-00573-6DOI Listing
August 2020

The efficacy of venetoclax and hypomethylating agents in acute myeloid leukemia with extramedullary involvement.

Leuk Lymphoma 2020 Aug 19;61(8):2020-2023. Epub 2020 Mar 19.

Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2020.1742908DOI Listing
August 2020

Ruxolitinib for the treatment of graft-versus-host disease.

Expert Rev Clin Immunol 2020 Apr 1;16(4):347-359. Epub 2020 Apr 1.

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2020.1740592DOI Listing
April 2020

Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients: A Phase 2, Randomized Clinical Trial.

Ann Intern Med 2020 03 11;172(5):306-316. Epub 2020 Feb 11.

City of Hope Comprehensive Cancer Center and the Beckman Research Institute of City of Hope, Duarte, California (C.L., J.L., C.R.L., Q.Z., J.M., T.K., A.D., N.H., S.F., D.J.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M19-2511DOI Listing
March 2020

Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.

Biol Blood Marrow Transplant 2020 May 5;26(5):e94-e100. Epub 2020 Feb 5.

National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.01.024DOI Listing
May 2020

Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.

Leuk Res 2019 12 28;87:106230. Epub 2019 Sep 28.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106230DOI Listing
December 2019

RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.

Transfusion 2019 11 10;59(11):3371-3385. Epub 2019 Oct 10.

Division of Transfusion Medicine, Department of Pathology, City of Hope National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.15531DOI Listing
November 2019

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.

Haematologica 2020 05 26;105(5):1329-1338. Epub 2019 Sep 26.

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2019.220756DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193485PMC
May 2020

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia.

Br J Haematol 2019 10 22;187(2):e45-e48. Epub 2019 Aug 22.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.16166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786919PMC
October 2019

Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.

Biol Blood Marrow Transplant 2019 10 28;25(10):2002-2007. Epub 2019 Jun 28.

Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.023DOI Listing
October 2019

Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia.

Bone Marrow Transplant 2020 02 14;55(2):473-475. Epub 2019 May 14.

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-019-0553-xDOI Listing
February 2020

Post-Allogeneic Hematopoietic Stem Cell Transplantation Eculizumab as Prophylaxis Against Hemolysis and Thrombosis for Patients with Hematologic Disorders Associated with Paroxysmal Nocturnal Hemoglobinuria Clones.

Biol Blood Marrow Transplant 2019 05 29;25(5):e183-e185. Epub 2019 Jan 29.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.01.025DOI Listing
May 2019

Rapid Acquisition of Cytomegalovirus-Specific T Cells with a Differentiated Phenotype, in Nonviremic Hematopoietic Stem Transplant Recipients Vaccinated with CMVPepVax.

Biol Blood Marrow Transplant 2019 04 16;25(4):771-784. Epub 2018 Dec 16.

Department of Experimental Therapeutics, Beckman Research Institute of City of Hope, City of Hope Comprehensive Cancer Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183089
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.12.070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453718PMC
April 2019

Effect of isavuconazole on tacrolimus and sirolimus serum concentrations in allogeneic hematopoietic stem cell transplant patients: A drug-drug interaction study.

Transpl Infect Dis 2019 Feb 23;21(1):e13007. Epub 2018 Oct 23.

College of Pharmacy, Western University of Health Sciences, Pomona, California.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/tid.13007
Publisher Site
http://dx.doi.org/10.1111/tid.13007DOI Listing
February 2019

A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection.

Expert Rev Vaccines 2018 10 3;17(10):889-911. Epub 2018 Oct 3.

d Center for Gene Therapy , Hematological Malignancy and Stem Cell Transplantation Institute, City of Hope , Duarte , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14760584.2018.1526085DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343505PMC
October 2018

Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.

Biol Blood Marrow Transplant 2019 02 15;25(2):287-292. Epub 2018 Sep 15.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California; Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183056
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.09.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502508PMC
February 2019

Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell-Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide.

J Clin Oncol 2017 Sep 23;35(26):3002-3009. Epub 2017 Jun 23.

Asad Bashey, Melhem Solh, The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA; Mei-Jie Zhang, Andrew St. Martin, Trevor Argall, Mehdi Hamadani, and Mary Eapen, Medical College of Wisconsin, Milwaukee, WI; Shannon R. McCurdy and Ephraim Joseph Fuchs, The Johns Hopkins Hospital, Baltimore, MD; Claudio Anasetti, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL; Stefan O. Ciurea, MD Anderson Cancer Center, Houston, TX; Omotayo Fasan, The Center for Bone Marrow Transplantation at Geisinger Medical Center, Danville; Sameh Gaballa, Thomas Jefferson University Hospital, Philadelphia, PA; Pashna Munshi and Scott Rowley, MedStar Georgetown University Hospital, Washington, DC; Monzr M. Al Malki and Ryotaro Nakamura, City of Hope National Medical Center, Duarte, CA; Paul V. O'Donnell, Massachusetts General Hospital; Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Miguel-Angel Perales, Memorial Sloan Kettering Cancer Center, New York, NY; Kavita Raj, King's College Hospital, London; Vanderson Rocha, Churchill Hospital, Oxford, United Kingdom; Rizwan Romee, Barnes Jewish Hospital, St Louis, MO; Scott Rowley, Hackensack University Medical Center, Hackensack, NJ; and Rachel B. Salit, Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.8428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590802PMC
September 2017

Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.

Am J Hematol 2017 Feb;92(2):E18-E19

Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24604DOI Listing
February 2017

Outcome of Second Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Lymphoblastic Leukemia.

Clin Lymphoma Myeloma Leuk 2016 09 8;16(9):519-522. Epub 2016 Jun 8.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2016.06.005DOI Listing
September 2016

Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

Biol Blood Marrow Transplant 2016 10 23;22(10):1900-1903. Epub 2016 Jun 23.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.022DOI Listing
October 2016

Fabrication of gold microstructures using negative photoresists doped with gold ions through two-photon excitation.

Phys Chem Chem Phys 2016 Jun;18(25):17024-8

Faculty of Materials Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo, Kyoto, 606-8585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c6cp02577cDOI Listing
June 2016

A spiropyran-based X-ray sensitive fiber.

Chem Commun (Camb) 2015 Jun;51(56):11170-3

Department of Macromolecular Science and Engineering, Graduate School of Science and Technology, Kyoto Institute of Technology, Matsugasaki, Sakyo, Kyoto 606-8585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5cc03977kDOI Listing
June 2015

Management of drug interaction between posaconazole and sirolimus in patients who undergo hematopoietic stem cell transplant.

Pharmacotherapy 2015 Jun 3;35(6):578-85. Epub 2015 Jun 3.

Department of Pharmacy, City of Hope National Medical Center, Duarte, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/phar.1600DOI Listing
June 2015

INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.

Cancer Discov 2015 Jul 16;5(7):730-9. Epub 2015 Apr 16.

Research Center for Biosignal, Akita University, Akita, Japan. Department of Medical Biology, Akita University Graduate School of Medicine, Akita, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-14-1329DOI Listing
July 2015

Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy.

Biol Blood Marrow Transplant 2015 Jan 22;21(1):55-9. Epub 2014 Sep 22.

Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272909PMC
January 2015

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

J Clin Oncol 2014 Oct 25;32(29):3264-74. Epub 2014 Aug 25.

Celalettin Ustun, Ryan Shanley, Gregory Vercellotti, and Daniel Weisdorf, University of Minnesota, Minneapolis; William J. Hogan, Mayo Clinic, Rochester, MN; Andreas Reiter and Sebastian Kreil, Universitätsmedizin Mannheim, Mannheim; Herrad Baurmann, Stiftung Deutsche Klinik für Diagnostik, Wiesbaden; Bernd Gruhn, Jena University Hospital, Jena; Tanja Gromke, University of Essen, Essen; Eva Maria Wagner, Universitätsmedizin Mainz, Mainz; Martin Bornhäuser, Universitätsklinikum Dresden, Dresden; Christoph Schmid, Klinikum Augsburg, Ausburg, Germany; Bart L. Scott and H. Joachim Deeg, University of Washington, Seattle, WA; Ryotaro Nakamura, City of Hope National Medical Center, Duarte; Vinod Pullarkat, University of Southern California, Los Angeles, CA; Gandhi Damaj, Université de Caen, Faculté de Médecine, Caen; Faezeh Legrand, Nice University Hospital, Nice, and Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC); Ibrahim Yakoub-agha, Centre Hospitalier Régionale Universitaire, Lille; Olivier Hermine, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Necker Enfants-Malades, Université Paris 5 Faculté de Médecine et AP-HP Necker-Enfants Malades, and Centre de Référence des Mastocytoses, Paris, France; Miguel-Angel Perales and Esperanza B. Papadopoulos, Memorial Sloan-Kettering Cancer Center; Tsiporah Shore, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY; Robert Stuart, Medical University of South Carolina, Charleston, SC; Michael Doubek, Masaryk University, Brno, Czech Republic; Jack W. Hsu, University of Florida, Gainesville, FL; Eleni Tholouli, Manchester Royal Infirmary, Manchester, United Kingdom; Lucy A. Godley, University of Chicago, Chicago, IL; Livio Pagano, Università Cattolica del Sacro Cuore, Milan; Maria Teresa Van Lint, Istituto Di Ricovero e Cura a Carattere Scientifico San Martino-IST, Genova, Italy; Andrew Gilman, Levine Children's Hospital, Charlotte, NC; Tor Shwayder, Henry F

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.2018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876356PMC
October 2014

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: considerations for evidence-based GVHD prophylaxis.

Expert Rev Hematol 2014 Jun 4;7(3):407-21. Epub 2014 Apr 4.

Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.898561DOI Listing
June 2014

Ex vivo detection of CD8 T cells specific for H-Y minor histocompatibility antigens in allogeneic hematopoietic stem cell transplant recipients.

Transpl Immunol 2014 May 26;30(4):128-35. Epub 2014 Feb 26.

Division of Translational Vaccine Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute of the City of Hope, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2014.02.001DOI Listing
May 2014

Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease.

Inflammation 2013 Feb;36(1):177-85

Department of Diabetes, Endocrinology and Metabolism, City of Hope National Medical Center, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10753-012-9533-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546172PMC
February 2013

KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).

Hum Immunol 2012 Nov 30;73(11):1109-15. Epub 2012 Aug 30.

CMV Laboratory in the Department of Virology, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humimm.2012.08.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478408PMC
November 2012

Non-host resistance to penetration and hyphal growth of Magnaporthe oryzae in Arabidopsis.

Sci Rep 2011 25;1:171. Epub 2011 Nov 25.

Department of Bioscience, Fukui Prefectural University , Fukui, 910-1195, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep00171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3240950PMC
September 2013

A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.

Biol Blood Marrow Transplant 2012 Mar 27;18(3):432-40. Epub 2011 Jul 27.

Department of Hematology/Hematopoietic Cell Transplantation, City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2011.07.017DOI Listing
March 2012